TNFRSF8 and anaplastic large cell lymphoma: Antibody-drug conjugates (ADCs) or immunotoxins such as brentuximab vedotin (adcetris) is an antibody targeting CD30, conjugated to a cytotoxic agent used to treat patients with anaplastic large cell lymphoma (ALCL).